🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06350370
Recruiting Not applicable

Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study

NCT06350370 · tracked via the Priya Life Science China tracker
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Not applicable
Started
2019-01-01
Last updated
2024-04-05

Condition(s) studied

Colorectal Cancer

Investigational drug(s) / intervention(s)

Natural orifice specimen extraction

Natural orifice specimen extraction: We perform laparoscopic colorectal cancer resection, intracorporeal anastomosis and transanal or transvaginal specimen extraction

Study summary

Natural orifice specimen extraction surgery (NOSES) has gained widespread recognition among scholars and has gradually been promoted and popularized around the world. However, the development of NOSES is still in the exploratory stage and there is a lack of strong evidence from evidence-based medicine to support its feasibility and safety, which has greatly affected its clinical application and development. Based on this, at the call of Professor Xishan Wang, the Chinese NOSES Alliance conducted a large retrospective clinical study involving multiple centers. By summarizing the NOSES cases of nearly 100 centers in China, the study aims to clarify the current status of NOSES surgery in China. Additionally, a comprehensive analysis and summary was conducted by combining the basic information of NOSES patients, perioperative data, postoperative pathological data, and follow-up information to further demonstrate the safety and feasibility of NOSES in the treatment of colorectal cancer. This study also provides more real and objective evidence-based medicine support for the promotion and development of NOSES surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Pathological diagnosis of primary malignant tumor in the colon or rectum; 2. The surgery meets the definition in the "Consensus of NOSES Experts in Colorectal Cancer"; Exclusion Criteria: 1. Postoperative pathological diagnosis does not belong to primary malignant tumors in the colon or rectum; 2. The surgery does not meet the definition in the "Consensus of NOSES Experts in Colorectal Cancer".

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cancer Hospital Chinese Academy of Medical Sciences Beijing Beijing Municipality Recruiting

More Cancer Institute and Hospital, Chinese Academy of Medical Sciences trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06350370 on ClinicalTrials.gov ↗ ← All trials in China